Health CanadaGeneral Alert
Suspension of marketing of Raptiva (efalizumab) in Canada - For Health Professio...
Published: February 20, 2009Recall ID: 25420Category: generalCountry: Canada
Product Description & Identification
Suspension of marketing of Raptiva (efalizumab) in Canada - For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 25420 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/suspension-marketing-raptiva-efalizumab-canada-health-professionals |
| Title | Suspension of marketing of Raptiva (efalizumab) in Canada - For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2009-02-20 |
| Organization | Marketed health products |